Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5
van der Heijde, Désirée, Mease, Philip J, Landewé, Robert B M, Rahman, Proton, Tahir, Hasan, Singhal, Atul, Boettcher, Elke, Navarra, Sandra, Zhu, Xuan, Ligozio, Gregory, Readie, Aimee, Mpofu, ShepharJournal:
Rheumatology
DOI:
10.1093/rheumatology/kez420
Date:
October, 2019
File:
PDF, 434 KB
2019
File converter
More search results
More benefits 
